IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
Wei Mu(Tongji Hospital), Richard J. Johnson(University of Colorado Anschutz Medical Campus), Bernardo Rodríguez‐Iturbe(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Xiaosen Ouyang(University of Florida), Vince A. Chiodo, Pedro E. Cruz, Mark A. Atkinson(University of Florida), David A. Long(Great Ormond Street Hospital), Anupam Agarwal(University of Alabama at Birmingham), William W. Hauswirth(University of Florida), Li Zhang(Fourth Hospital of Changsha), Olena Glushakova(University of Virginia Cancer Center), Carmen Roncal(University of Colorado Anschutz Medical Campus)
Cited by 154
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k